Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19

Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19

Background: Whilst there is literature on the impact of SARS viruses in the severely immunosuppressed, less is known about the link between routine immunosuppressant use and outcome in COVID-19. Consequently, guidelines on their use vary depending on specific patient populations. Methods: The study...

Full description

Bibliographic Details
Main Authors: Phyo K. Myint, Ben Carter, Fenella Barlow-Pay, Roxanna Short, Alice G. Einarsson, Eilidh Bruce, Kathryn McCarthy, Alessia Verduri, Jemima Collins, James Hesford, Frances Rickard, Emma Mitchell, Mark Holloway, Aine McGovern, Arturo Vilches-Moraga, Philip Braude, Lyndsay Pearce, Michael Stechman, Angeline Price, Terence J. Quinn, Enrico Clini, Susan Moug, Jonathan Hewitt
Format: Article
Language:English
Published: SAGE Publishing 2021-02-01
Series:Therapeutic Advances in Drug Safety
Online Access:https://doi.org/10.1177/2042098620985690

Internet

https://doi.org/10.1177/2042098620985690

Similar Items